The Board has denied the Veteran's claim for service connection for chronic hoarseness and remanded the issue of service connection for monoclonal gammopathy.
The deciding factor: There is no current diagnosis of a chronic hoarseness disability, and the VA examiner found that the Veteran’s voice was not characterized as pain or a functional impairment.
- Claimed conditions
- chronic hoarseness, monoclonal gammopathy
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- April 15, 2019
- Citation
- 19129220
Veterans Law Judge
Decisions by this judge: 317 · Granted: 19% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 19129220.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Dismissed
The Board dismissed the appeal concerning service connection for monoclonal gammopathy and multiple myeloma due to the appellant's withdrawal of the appeal prior to a decision.
- Whole decision: Remanded (sent back)
The Board has remanded the claims of service connection for various conditions due to a lack of STRs and personnel records, which may indicate potential exposure to ionizing radiation or toxic exposure during service. The Veteran's participation in a TERA while stationed in Japan is also under review.
- Whole decision: Dismissed
The Board dismissed the appeal for an increased evaluation greater than 20 percent for diabetes mellitus as it was not reasonably raised by the record prior to the Veteran's death.
- Whole decision: Granted
The Board granted service connection for diabetes, hypertension, monoclonal gammopathy, diabetic peripheral neuropathy of the bilateral femoral and sciatic nerves, chronic kidney disease, anemia, and upper extremity diabetic peripheral neuropathy on a direct basis or secondary to diabetes, effective November 5, 2021.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.